Biosimilar Trade Secrets: Coherus Hiring Of Amgen Exec Leads To Theft Suit
Executive Summary
Three months before user fee date for Coherus' Neulasta (pegfilgrastim) biosimilar, Amgen claims company stole confidential information including pricing and contracting strategies.
You may also be interested in...
Amgen Alleges 'Massive Conspiracy' By Employees Who Joined Coherus And KBI
Details emerge on the breadth of Amgen's complaint against Coherus and former Amgen employees; trade secrets on Neulasta pricing and contract strategies allegedly stolen via USB drives.
Amgen Alleges 'Massive Conspiracy' By Employees Who Joined Coherus And KBI
Details emerge on the breadth of Amgen's complaint against Coherus and former Amgen employees; trade secrets on Neulasta pricing and contract strategies allegedly stolen via USB drives.
Ex-Pfizer Employee Overseeing Xeljanz Global Marketing Sued For Trade Secret Theft
Pfizer says its former global marketing director emailed and copied hundreds of documents on product launch plans and steps to obtain government approvals before leaving the company in January.